Clinical trial Recruiting at 1 site Observational Ages 15 to 18

Examining pain empathy in adolescents with nonsuicidal self-injury

Official title: Abnormal Neural Pain Empathic Processing in Adolescents With Non-suicidal Self-Injury

Run by University of Electronic Science and Technology of China · NCT05968313 · Data updated 2026-11-12

This study is trying to see how the brains of teens who hurt themselves on purpose respond to feelings of pain in others compared to teens who don’t, to better understand their emotional challenges.

More Nonsuicidal Self Injury trials

Quick facts

Study typeObservational
Ages15 Years to 18 Years
SexAll
Enrollment80 (estimated)
SponsorUniversity of Electronic Science and Technology of China
Academic / other
Locations1 site (Chengdu, Sichuan)
StatusRecruiting
StartedDecember 6, 2023
Main results expectedJuly 2026
Study endsJuly 2027
Registry record updatedApril 11, 2024
Trial IDNCT05968313 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adolescents aged 15-18 who are right-handed and have engaged in nonsuicidal self-injury behaviors.

Probably not a fit

Patients with high suicidal risk, significant psychiatric disorders, or those currently undergoing specific therapies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the neural processing of pain empathy in adolescents who engage in nonsuicidal self-injury (NSSI) compared to healthy controls. Using functional magnetic resonance imaging (fMRI), the study will recruit 40 adolescents with NSSI behaviors and 40 healthy adolescents to assess their brain activity in response to pain empathy stimuli. The focus is on understanding how altered empathic processing may relate to the emotional and interpersonal challenges faced by these adolescents. By comparing the neural responses of both groups, the study seeks to shed light on the underlying mechanisms of pain empathy in NSSI.

Why it matters

Potential benefit: If successful, this study could enhance understanding of the emotional processing in adolescents with NSSI, potentially leading to improved therapeutic approaches.

How similar studies have gone: While studies on pain empathy exist, this specific examination of NSSI adolescents using fMRI is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 15-18 years
* right-handed
* normal or corrected normal visual acuity
* meet the proposed DSM-5 frequency criteria (e.g., ≥5 days of NSSI behaviors in the past year)

Exclusion Criteria:

* diagnosis of borderline personality disorder, major depressive disorder, other
* psychiatric disorders, etc.
* high suicidal risk
* recent use of medications that can affect neural activity
* have received or are receiving Dialectical Behavior Therapy (DBT) other treatment for emotional problems within the past 6 months
* have a contraindication to MRI scanning (e.g., metal implants, claustrophobia or other conditions that make them inappropriate for MRI scanning)

Where it's running

  • Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China
    Chengdu, Sichuan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.